Critical Care Department, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
PLoS One. 2023 Aug 17;18(8):e0290033. doi: 10.1371/journal.pone.0290033. eCollection 2023.
Heat and moisture exchanger (HME) filters are commonly used as passive circuit humidifiers during mechanical ventilation, however, are only ~80% efficient. As a result, patients that undergo mechanical ventilation in critical care with HME filter circuits will be exposed to partial airway humidification. This is associated with detrimental effects including increased secretion load which has been shown to be an independent predictor of failed extubation. Nebulised normal saline is commonly utilised to supplement circuit humidification in ventilated patients with high secretion loads, although there are no randomised control trials evaluating its use. Novel vibrating mesh nebulisers generate a fine aerosol resulting in deeper lung penetration, potentially offering a more effective means of nebulisation in comparison to jet nebulisers. The primary aim of this study is to compare the viscosity of respiratory secretions after treatment with nebulised normal saline administered via vibrating mesh nebuliser or jet nebuliser.
This randomised controlled trial is enrolling 60 mechanically ventilated adult critical care patients breathing on HME filter circuits with high secretion loads. Recruited patients will be randomised to receive nebulised saline via 3 modalities: 1) Continuous vibrating mesh nebuliser; 2) Intermittent vibrating mesh nebuliser or 3) Intermittent jet nebuliser. Over the 72-hr study period, the patients' sputum viscosity (measured using a validated qualitative sputum assessment tool) and physiological parameters will be recorded by an unblinded assessor. A median reduction in secretion viscosity of ≥0.5 on the qualitative sputum assessment score will be deemed as a clinically significant improvement between treatment groups at analysis.
At the conclusion of this trial, we will provisionally determine if nebulised normal saline administered via vibrating mesh nebulisation is superior to traditional jet nebulisation in terms of reduced respiratory secretion viscosity in intubated patients. Results from this pilot study will provide information to power a definitive clinical study.
ClinicalTrails.Gov Registry (NCT05635903).
热和湿气交换器(HME)过滤器在机械通气期间通常用作被动回路加湿器,但效率仅约为 80%。因此,在重症监护中接受 HME 过滤器回路机械通气的患者将暴露于部分气道加湿。这与有害影响有关,包括增加分泌物负荷,已证明分泌物负荷是拔管失败的独立预测因素。在高分泌物负荷的通气患者中,通常使用雾化生理盐水来补充回路加湿,但没有评估其使用的随机对照试验。新型振动网式雾化器产生细雾气溶胶,可实现更深的肺部渗透,与射流雾化器相比,可能提供更有效的雾化方式。本研究的主要目的是比较通过振动网式雾化器或射流雾化器雾化生理盐水治疗后呼吸分泌物的粘度。
这是一项随机对照试验,正在招募 60 名在 HME 过滤器回路中接受机械通气的成年重症监护患者,这些患者的分泌物负荷较高。招募的患者将随机接受 3 种方式的雾化生理盐水治疗:1)连续振动网式雾化器;2)间歇振动网式雾化器或 3)间歇射流雾化器。在 72 小时的研究期间,由未设盲评估者记录患者的痰液粘度(使用经过验证的定性痰液评估工具测量)和生理参数。分析时,定性痰液评估评分中分泌物粘度降低≥0.5 被认为是治疗组之间的临床显著改善。
在试验结束时,我们将暂定确定在插管患者中,通过振动网式雾化器给予的雾化生理盐水是否比传统射流雾化器在降低呼吸分泌物粘度方面更优。这项初步研究的结果将提供信息,以支持一项确定性临床试验。
ClinicalTrials.Gov 注册表(NCT05635903)。